Paper33724070
Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry.
Pearson LA and 6 others. SLAS Discov, 2021. Cited by 33 papers, by iCite.
Cite this record
ConductScience Library. Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry. Papers, record 33724070. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/33724070
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Development of a High-Throughput Screening Assay to Identify Inhibitors of the SARS-CoV-2 Guanine-N7-Methyltransferase Using RapidFire Mass Spectrometry.
- PubMed
Topics26
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antiviral Agents | Major topic |
| Exoribonucleases | Major topic |
| High-Throughput Screening Assays | Major topic |
| Nitro Compounds | Major topic |
| RNA Caps | Major topic |
| RNA, Viral | Major topic |
| SARS-CoV-2 | Major topic |
| Thiazoles | Major topic |
| Viral Nonstructural Proteins | Major topic |
| Antiparasitic Agents | |
| COVID-19 | |
| Cloning, Molecular | |
| Drug Repositioning | |
| Enzyme Assays | |
| Enzyme Inhibitors | |
| Escherichia coli | |
| Gene Expression | |
| Genetic Vectors | |
| Humans | |
| Kinetics | |
| Mass Spectrometry | |
| Methylation | |
| Prescription Drugs | |
| Recombinant Fusion Proteins | |
| Small Molecule Libraries | |
| Virus Replication |
Source PubMed
Grants5
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| MC_PC_19034 | Medical Research Council | United Kingdom | PubMed | |
| 203134/Z/16/Z | Wellcome Trust | United Kingdom | PubMed | |
| European Research Council | International | PubMed | ||
| MR/K024213/1 | Medical Research Council | United Kingdom | PubMed | |
| MC_PC_18044 | Medical Research Council | United Kingdom | PubMed |
Source PubMed
References25
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 25074927 | Coronavirus Nsp10, a critical co-factor for activation of multiple replicative enzymes. | J Biol Chem | 2014 | https://conductscience.org/library/papers/25074927 | PubMed |
| 2 | 32020029 | Remdesivir and chloroquine effectively inhibit the recently emerged novel coronavirus (2019-nCoV) in vitro. | Cell Res | 2020 | https://conductscience.org/library/papers/32020029 | PubMed |
| 3 | 15220459 | Human coronavirus 229E nonstructural protein 13: characterization of duplex-unwinding, nucleoside triphosphatase, and RNA 5'-triphosphatase activities. | J Virol | 2004 | https://conductscience.org/library/papers/15220459 | PubMed |
| 4 | 27009949 | Mutagenesis of Coronavirus nsp14 Reveals Its Potential Role in Modulation of the Innate Immune Response. | J Virol | 2016 | https://conductscience.org/library/papers/27009949 | PubMed |
| 5 | 32243297 | Coronaviruses and SARS-CoV-2: A Brief Overview. | Anesth Analg | 2020 | https://conductscience.org/library/papers/32243297 | PubMed |
| 6 | 30312682 | mRNA cap regulation in mammalian cell function and fate. | Biochim Biophys Acta Gene Regul Mech | 2019 | https://conductscience.org/library/papers/30312682 | PubMed |
| 7 | 32443810 | A Structural View of SARS-CoV-2 RNA Replication Machinery: RNA Synthesis, Proofreading and Final Capping. | Cells | 2020 | https://conductscience.org/library/papers/32443810 | PubMed |
| 8 | 24269475 | SARS-CoV ORF1b-encoded nonstructural proteins 12-16: replicative enzymes as antiviral targets. | Antiviral Res | 2014 | https://conductscience.org/library/papers/24269475 | PubMed |
| 9 | 27252528 | Mutagenesis of S-Adenosyl-l-Methionine-Binding Residues in Coronavirus nsp14 N7-Methyltransferase Demonstrates Differing Requirements for Genome Translation and Resistance to Innate Immunity. | J Virol | 2016 | https://conductscience.org/library/papers/27252528 | PubMed |
| 10 | 26159422 | Structural basis and functional analysis of the SARS coronavirus nsp14-nsp10 complex. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/26159422 | PubMed |
| 11 | 33340543 | Force-dependent stimulation of RNA unwinding by SARS-CoV-2 nsp13 helicase. | Biophys J | 2021 | https://conductscience.org/library/papers/33340543 | PubMed |
| 12 | 25451075 | A screen of the NIH Clinical Collection small molecule library identifies potential anti-coronavirus drugs. | Antiviral Res | 2015 | https://conductscience.org/library/papers/25451075 | PubMed |
| 13 | 10838414 | A Simple Statistical Parameter for Use in Evaluation and Validation of High Throughput Screening Assays. | J Biomol Screen | 1999 | https://conductscience.org/library/papers/10838414 | PubMed |
| 14 | 28676301 | Toward the identification of viral cap-methyltransferase inhibitors by fluorescence screening assay. | Antiviral Res | 2017 | https://conductscience.org/library/papers/28676301 | PubMed |
| 15 | 15249217 | Potent and selective inhibition of SARS coronavirus replication by aurintricarboxylic acid. | Biochem Biophys Res Commun | 2004 | https://conductscience.org/library/papers/15249217 | PubMed |
| 16 | 19208801 | Functional screen reveals SARS coronavirus nonstructural protein nsp14 as a novel cap N7 methyltransferase. | Proc Natl Acad Sci U S A | 2009 | https://conductscience.org/library/papers/19208801 | PubMed |
| 17 | 10984012 | Nitazoxanide: pharmacokinetics and metabolism in man. | Int J Clin Pharmacol Ther | 2000 | https://conductscience.org/library/papers/10984012 | PubMed |
| 18 | 19915615 | Enhanced mRNA cap methylation increases cyclin D1 expression and promotes cell transformation. | Oncogene | 2010 | https://conductscience.org/library/papers/19915615 | PubMed |
| 19 | 21637813 | Crystal structure and functional analysis of the SARS-coronavirus RNA cap 2'-O-methyltransferase nsp10/nsp16 complex. | PLoS Pathog | 2011 | https://conductscience.org/library/papers/21637813 | PubMed |
| 20 | 20421945 | In vitro reconstitution of SARS-coronavirus mRNA cap methylation. | PLoS Pathog | 2010 | https://conductscience.org/library/papers/20421945 | PubMed |
Cited by25
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 33 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42655159 | Structural and Mechanistic Perspectives on SARS-CoV-2 Nonstructural Protein 14-Mediated Cap Formation and Drug Discovery. | Microorganisms | 2026 | https://conductscience.org/library/papers/42655159 | PubMed |
| 42053284 | Small is big: growing impact of small molecule mass spectrometry in infectious disease drug development. | mSphere | 2026 | https://conductscience.org/library/papers/42053284 | PubMed |
| 41502823 | Crystallographic characterisation and development of bi-substrate inhibitors of coronavirus nsp14 methyltransferase. | RSC Med Chem | 2026 | https://conductscience.org/library/papers/41502823 | PubMed |
| 41089484 | Design and Synthesis of Pyrazoline Inhibitors of SARS-CoV‑2 NSP14. | ACS Med Chem Lett | 2025 | https://conductscience.org/library/papers/41089484 | PubMed |
| 40684946 | Overcoming a false-positive mechanism in RapidFire MRM-based high throughput screening. | SLAS Discov | 2025 | https://conductscience.org/library/papers/40684946 | PubMed |
| 39869500 | Characterisation of RNA guanine-7 methyltransferase (RNMT) using a small molecule approach. | Biochem J | 2025 | https://conductscience.org/library/papers/39869500 | PubMed |
| 39818457 | Mechanisms and rationales of SAM homeostasis. | Trends Biochem Sci | 2025 | https://conductscience.org/library/papers/39818457 | PubMed |
| 39478665 | Perspective for Drug Discovery Targeting SARS Coronavirus Methyltransferases: Function, Structure and Inhibition. | J Med Chem | 2024 | https://conductscience.org/library/papers/39478665 | PubMed |
| 38516599 | N-Arylsulfonamide-based adenosine analogues to target RNA cap N7-methyltransferase nsp14 of SARS-CoV-2. | RSC Med Chem | 2024 | https://conductscience.org/library/papers/38516599 | PubMed |
| 37546609 | Rational Design of Highly Potent SARS-CoV-2 nsp14 Methyltransferase Inhibitors. | ACS Omega | 2023 | https://conductscience.org/library/papers/37546609 | PubMed |
| 37348028 | Broad-Spectrum Small-Molecule Inhibitors Targeting the SAM-Binding Site of Flavivirus NS5 Methyltransferase. | ACS Infect Dis | 2023 | https://conductscience.org/library/papers/37348028 | PubMed |
| 37259914 | Preparing for the next viral threat with broad-spectrum antivirals. | J Clin Invest | 2023 | https://conductscience.org/library/papers/37259914 | PubMed |
| 37060263 | A universal fluorescence polarization high throughput screening assay to target the SAM-binding sites of SARS-CoV-2 and other viral methyltransferases. | Emerg Microbes Infect | 2023 | https://conductscience.org/library/papers/37060263 | PubMed |
| 36694312 | Quasi-continuous infrared matrix-assisted laser desorption electrospray ionization source coupled to a quadrupole time-of-flight mass spectrometer for direct analysis from well plates. | J Mass Spectrom | 2023 | https://conductscience.org/library/papers/36694312 | PubMed |
| 36677825 | 3-(Adenosylthio)benzoic Acid Derivatives as SARS-CoV-2 Nsp14 Methyltransferase Inhibitors. | Molecules | 2023 | https://conductscience.org/library/papers/36677825 | PubMed |
| 36662458 | Detection of Glycosaminoglycans in Biological Specimens. | Methods Mol Biol | 2023 | https://conductscience.org/library/papers/36662458 | PubMed |
| 36445904 | High throughput bioluminescent assay to characterize and monitor the activity of SARS-CoV-2 methyltransferases. | PLoS One | 2022 | https://conductscience.org/library/papers/36445904 | PubMed |
| 36097498 | Bisubstrate Inhibitors of Severe Acute Respiratory Syndrome Coronavirus-2 Nsp14 Methyltransferase. | ACS Med Chem Lett | 2022 | https://conductscience.org/library/papers/36097498 | PubMed |
| 35682757 | The Role of Antibodies in the Treatment of SARS-CoV-2 Virus Infection, and Evaluating Their Contribution to Antibody-Dependent Enhancement of Infection. | Int J Mol Sci | 2022 | https://conductscience.org/library/papers/35682757 | PubMed |
| 35412633 | Chemical biology and medicinal chemistry of RNA methyltransferases. | Nucleic Acids Res | 2022 | https://conductscience.org/library/papers/35412633 | PubMed |
Genes2
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes | Source |
|---|---|---|---|---|
| IFNB1 | 3456 | PubTator's text mining | https://conductscience.org/library/genes/3456 | NCBI Gene |
| RNMT | 8731 | PubTator's text mining | https://conductscience.org/library/genes/8731 | NCBI Gene |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/33724070
GET https://conductscience.org/api/papers/v1/33724070/references?page=2